Viewing Study NCT02797132


Ignite Creation Date: 2025-12-24 @ 9:31 PM
Ignite Modification Date: 2026-02-22 @ 4:13 AM
Study NCT ID: NCT02797132
Status: COMPLETED
Last Update Posted: 2018-10-30
First Post: 2016-05-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del
Sponsor: Vertex Pharmaceuticals Incorporated
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cystic Fibrosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CF View